Kaklamani's Insights on EMERALD Trial and Elacestrant in Advanced Breast Cancer
Season 5, Episode 17, Sep 26, 02:45 PM
In this episode of Targeted Talks, Virginia Kaklamani, MD, DSc, professor of medicine in the Division of Hematology-Medical Oncology at The University of Texas Health Science Center San Antonio and the leader of the breast cancer program at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, discusses the background, findings, and implications of the phase 3 EMERALD trial.